Bausch + Lomb Launches enVista Aspire Monofocal and Toric IOLs in the European Union

Bausch + Lomb announced the commercial launch of the enVista Aspire monofocal and toric IOLs in the European Union after receiving a CE Mark late last year.

According to B+L, enVista Aspire combines 'intermediate optimized' optics, which are designed for a broader depth of focus, with the benefits of the enVista platform to address vision needs in today’s modern, digital world.

“Surgeons around the world have long known the benefits of the enVista platform,” Luc Bonnefoy, president, Surgical, Bausch + Lomb, said in a company news release. “In the US, where enVista Aspire is currently available, surgeons and their patients appreciate the features of these monofocal lenses that are designed for a broader depth of focus,* and we look forward to offering that feature in Europe as part of our comprehensive IOL portfolio.”

Unlike conventional spherical monofocal IOLs and lower-order aspheric IOLs, the enVista Aspire monofocal optics allow for a range of vision beyond one focal point. Like enVista MX60E, enVista Aspire offers a glistening-free optic material and controlled, efficient unfolding through Bausch + Lomb’s proprietary StableFlex Technology, which aids optic recovery.

For patients with astigmatism, enVista Aspire Toric IOLs provide a proven option for treatment of their astigmatism during cataract surgery. Featuring a +0.90 cylinder design, the enVista toric IOL platform can treat less than 1 diopter of astigmatism at the corneal plane. The AccuSet haptic design enables exceptional rotational stability, an important attribute for toric lenses, according to B+L. 

*Based on optical bench testing. MTF study in IS02 model cornea, comparison of MX60E and enVista Aspire.